A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency

Clinical trial NCT01289847 · COMPLETED

Trial details

NCT number: NCT01289847
Sponsor: Bio Products Laboratory
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Immune Deficiency Disorders Common Variable Immunodeficiency X-linked Agammaglobulinemia Hyper-IgM Syndrome Wiskott-Aldrich Syndrome

Start date: 2011-03-01
Primary completion: 2014-04-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.